PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-03-08

Date Title Company
08-Mar-2024 Ainos Reports Full Year 2023 Financial Results AccessWire
08-Mar-2024 Avenues Recovery Centers in Louisiana Designated as Blue Distinction(R) Centers AccessWire
08-Mar-2024 Sinceri Senior Living Welcomes New Community in Virginia AccessWire
08-Mar-2024 Empowering women in the pharma packaging boardroom MM Packaging
08-Mar-2024 Cresset Increases Its North America Presence with New Boston Site Cresset
08-Mar-2024 Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma Johnson & Johnson
08-Mar-2024 Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma Johnson & Johnson
08-Mar-2024 Roche presents positive topline CGM accuracy data at the 17th International Conference on Advanced Technologies and Treatments for Diabetes Roche
08-Mar-2024 AlzeCure presents new preclinical data with NeuroRestore ACD856 at leading Alzheimer's conference AlzeCure Pharma AB (publ)
08-Mar-2024 BioInnovation Institute provides EUR 7.8M in financial support as six promising companies enter its Venture House program BioInnovation Institute (BII)
08-Mar-2024 GENDER BALANCE AT WORK DRIVES GROWTH, HAYS STUDY FINDS Hays
08-Mar-2024 MitoRx Therapeutics Strengthens Scientific Advisory Board with Appointment of Four International Experts MitoRx Therapeutics
08-Mar-2024 Oxford BioTherapeutics Announces Launch of Enhanced Discovery Platform, OGAP®-Verify, at World ADC Conference 2024 Oxford BioTherapeutics
08-Mar-2024 ramarketing announces strategic leadership appointments to support global growth ramarketing
08-Mar-2024 WELLCOME APPOINTS MHP GROUP MHP Group Limited
08-Mar-2024 BioInnovation Institute provides EUR 7.8M in financial support as six promising companies enter its Venture House program BioInnovation Institute (BII)
08-Mar-2024 Curium Announces First Commercial Doses in Italy of PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer Curium
08-Mar-2024 Accumulus Synergy Adds Two World-Class Executives to Its Leadership Team Accumulus Synergy, Inc.
08-Mar-2024 US FDA grants Orphan Drug Designation for iOnctura’s first-in-class autotaxin cancer therapy iOnctura
08-Mar-2024 Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024 AccessWire